Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019
Xue Li, Xiaojin Feng, Xiaodong Sun, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 319
Post-COVID Syndrome: An Insight on Its Pathogenesis
Helena C. Maltezou, Androula Pavli, Athanassios Tsakris
Vaccines (2021) Vol. 9, Iss. 5, pp. 497-497
Open Access | Times Cited: 201
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Junhua Xie, Lien Van Hoecke, Roosmarijn E. Vandenbroucke
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 186
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It
Jonaid Ahmad Malik, Sakeel Ahmed, Mrunal Shinde, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 5, pp. 3586-3599
Open Access | Times Cited: 86
A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
Naciye Magusali, Andrew Graham, Thomas M. Piers, et al.
Brain (2021) Vol. 144, Iss. 12, pp. 3727-3741
Open Access | Times Cited: 83
Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
Yiyan Sun, Xiaohuan Xia, Diksha Basnet, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 61
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Ewa Rudnicka-Drożak, Paulina Drożak, Grzegorz Mizerski, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2146-2146
Open Access | Times Cited: 32
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 7
SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia
Risna Kanjirassery Radhakrishnan, Mahesh Kandasamy
American Journal of Alzheimer s Disease & Other Dementias® (2022) Vol. 37
Open Access | Times Cited: 27
Multiple Metabolites Derived from Mushrooms and Their Beneficial Effect on Alzheimer’s Diseases
Zijian Tong, Guodong Chu, Chenmeng Wan, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2758-2758
Open Access | Times Cited: 17
COVID-19 Accelerated Cognitive Decline in Elderly Patients with Pre-Existing Dementia Followed up in an Outpatient Memory Care Facility
Lucia Merla, M.C. Montesi, Jessica Ticali, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1845-1845
Open Access | Times Cited: 15
Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons
Cristina Di Primio, Paola Quaranta, Marianna Mignanelli, et al.
PNAS Nexus (2023) Vol. 2, Iss. 9
Open Access | Times Cited: 15
Unravelling the connection between COVID-19 and Alzheimer’s disease: a comprehensive review
Shah Rezlan Shajahan, Suresh Kumar, Muhammad Danial Che Ramli
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 6
Associations between neutrophil–lymphocyte ratio and risk of cognitive impairment among Chinese older adults
Xin Wang, Binbin Wang, Xueqing Du, et al.
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access
SARS-CoV-2: A synergy to the Alzheimer’s disease
Khaja Moinuddin Shaik, Deepak Kumar, Pirangi Srikanth, et al.
Journal of NeuroVirology (2025)
Closed Access
COVID-19 and Alzheimer’s Disease: A Literature Review
Louis Hardan, Dimitar Filtchev, Ratiba Kassem, et al.
Medicina (2021) Vol. 57, Iss. 11, pp. 1159-1159
Open Access | Times Cited: 32
Biomarkers of ageing and frailty may predict COVID-19 severity
Kailyn J. Wanhella, Carlos Fernández-Patrón
Ageing Research Reviews (2021) Vol. 73, pp. 101513-101513
Open Access | Times Cited: 32
Dementia Clinical Care in Relation to COVID-19
Angelo Bianchetti, Renzo Rozzini, Luca Bianchetti, et al.
Current Treatment Options in Neurology (2022) Vol. 24, Iss. 1, pp. 1-15
Open Access | Times Cited: 22
Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants
Kyonghwan Choe, Hyun‐Young Park, Muhammad Ikram, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1298-1298
Open Access | Times Cited: 22
Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer’s, and diabetes
Dicson Sheeja Malar, Kanika Verma, Mani Iyer Prasanth, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret K. Huber, Günter U. Höglinger, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 28
Neuropsychological Predictors of Fatigue in Post-COVID Syndrome
Jordi A. Matías‐Guiu, Cristina Delgado‐Alonso, María Díez‐Cirarda, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3886-3886
Open Access | Times Cited: 21
Association of Alzheimer’s Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study
Seok Jong Chung, Yoonkyung Chang, Jimin Jeon, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 2, pp. 701-710
Open Access | Times Cited: 19
The amplification of CNS damage in Alzheimer's disease due to SARS-CoV2 infection
Gerard J. Nuovo, David Suster, Dwitiya Sawant, et al.
Annals of Diagnostic Pathology (2022) Vol. 61, pp. 152057-152057
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top